Global Schizophrenia Drugs Market is expected to reach USD 7.9 billion by 2022. Schizophrenia is a serious disorder that affects how a person thinks, feels, and acts. People suffering from schizophrenia have difficulty distinguishing between real and reel, and expressing emotions. Schizophrenia is mainly observed in males than in females. Antipsychotic drugs are mainly prescribed, as they help to control symptoms like disorganized thinking, hallucinations, and delusions by blocking specific chemicals in the brain like serotonin and dopamine.

The antipsychotics drugs may be atypical and typical and are available in various forms like injection, tablet, or syrup. The symptoms involved can be positive, negative, or cognitive. The World Health Organization (WHO) has estimated that the disease around the world affects about 24 million people. The Schizophrenia Drugs Market is estimated to grow at a significant CAGR of 2.5% over the forecast period as the scope and its applications are rising enormously across the globe.

The report “Schizophrenia Drugs Market Size & Forecast Report, 2016 - 2022” is available now at https://www.millioninsights.com/industry-reports/schizophrenia-drugs-market

Rising occurrence of Schizophrenia disease as changing lifestyle, high demand for enhanced therapy by patients and physicians, developing R&D sectors with enhanced technology, and growing addictions like narcotics and alcohol are documented as major factors of Schizophrenia Drugs Market that are estimated to enhance the growth in the years to come. However, high cost of therapy, side effects caused by drugs, and lack of awareness in developing regions may restrain overall market in coming years. Schizophrenia Drugs industry is segmented based on therapeutic class, treatment, distribution channel, and region.

Third-Generation Antipsychotics, Second-Generation Antipsychotics, and other therapeutic class are explored in Schizophrenia Drugs in the forecast period. Others segment may include generics and First-Generation Antipsychotics. Second-Generation Antipsychotics comprises drugs like Risperdal, Vraylar, Invega, Saphris, Zyprexa, and others. On the other hand, Third-Generation Antipsychotics includes Aripiprazole. Second- and Third-Generation Antipsychotics sectors account for the majority market share and are estimated to continue its dominance in coming years. The drugs involved in second- & third-generation help to improve the treatment outcome and decrease the hospitalization.

Injectable and oral are the treatment action that could be explored in Schizophrenia Drugs in the forecast period. The market may be characterized based on distribution channels like rehabilitation centers, hospitals comprising hospital pharmacies, retail pharmacies, clinics, and others that could be explored in forecast period.

Globally, North America accounted for the substantial market growth of Schizophrenia Drugs and is estimated to lead the overall market in coming years. The reason behind the overall market growth could be developed healthcare infrastructure and R&D sectors, rising use of enhanced technology for the development of enhanced drugs, and rising awareness among populace regarding the disease. The United States is a major consumer of Schizophrenia Drugs in the region, as presence of key manufacturers mainly generic and it affects about 1% of the population and more than 2 million people in the U.S. alone.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing awareness regarding early diagnosis, developing healthcare infrastructure and R&D sectors, increasing disposable income, and growing major manufacturers in the region. The developing countries like India, Japan, and China are the major consumers of Schizophrenia Drugs in the region.

Request a Free Sample Copy of Schizophrenia Drugs Market Report @ https://www.millioninsights.com/industry-reports/schizophrenia-drugs-market/request-sample

The key players of Schizophrenia Drugs Market are Pfizer, Johnson & Johnson, Allergan, Bristol-Myers Squibb/ Otsuka Pharma, Vanda Pharma, AstraZeneca, Alkermes, Sumitomo Dainippon, and Eli Lilly. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

Market Segment:

Therapeutic Class Outlook (% Market Share; 2016 - 2022)
• Second-Generation Antipsychotics
• Risperdal (Risperidone)
• Invega (Paliperidone)
• Zyprexa (Olanzapine)
• Geodon (Ziprasidone)
• Seroquel (Quetiapine)
• Latuda (Lurasidone)
• Aristada (Aripiprazole Lauroxil)
• Fanapt (Iloperidone)
• Saphris (Asenapine)
• Vraylar (Cariprazine)
• Third-Generation Antipsychotics
• Abilify (Aripiprazole)
• Others
• First-Generation Antipsychotics
• Generics

Treatment Outlook (% Market Share; 2016 - 2022)
• Oral Antipsychotics
• Injectable Antipsychotics

Regional Outlook (% Market Share; 2016 - 2022)
• U.S.
• U.K.
• France
• Germany
• Italy
• Spain
• Japan

To read more reports of this category, Visit our blog: https://healthandpharmamarketers.tumblr.com 

What is Schizophrenia?

Schizophrenia is a very serious and chronic mental illness that affects close to 1% of the world population. Patients with schizophrenia often experience episodes leading to distortions of reality which ultimately leads to delusions and hallucinations. 

Symptoms of Schizophrenia

The most common symptoms of schizophrenia that can be seen early in life include:

• Isolating oneself from friends and family
• Having trouble focusing or concentrating and getting easily distracted
• Developing the habit of changing friends or social groups frequently
• Change in sleep pattern or difficulty sleeping
• Being easily agitated or irritated
• Poor academic performance and having trouble with school work
• Facing difficulty with personal relationships

Schizophrenia Diagnosis and Treatment 

• During the initial appointment checkup, the doctor needs to know the entire medical history of the patient and their family, followed by their normal mental health, mood patterns, and substance abuse problems. They may also ask for school or work performance reports to get insights into the cognitive abilities of the patient. 

• For the next step, the doctor may prescribe several blood tests, physical exam and imaging tests like Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI).
• Even psychometric assessments are essential to establish the diagnosis.

• For the final step and confirmed diagnosis, the patient should have experienced symptoms of ‘positive’ schizophrenia in a one-month period. These symptoms are hallucinations, delusions, and disorganized speech.

Cadabams is India’s leading Mental Health Rehab for Schizophrenia and other serious mental illnesses. Get schizophrenia treatment in india. 

Call us on our mental health helpline +91 96111 94949 for further details or Schizophrenia related emergencies. 

I’m writing this review as part of Rosie’s Book Review Team. If you are an author and are looking for reviews, I recommend you check here, as she manages a great group of reviewers and if they like your book, you’ve made it!

Having read and enjoyed Brian Cohn’s previous novel The Last Detective  (you can check my review here), I was very intrigued by his new novel. Although it also promised a mystery/thriller of sorts, this one was set firmly in the present, well, as firmly as anything can be when told by a character suffering from paranoid schizophrenia who rarely takes his medication. As I am a psychiatrist, and I read many thrillers, the book had a double interest for me.

As the description says, the story is told is narrated, in the first person, by the main character, the Brendan Meeks of the title. Although he is from a good family and had an affluent (if not the happiest) childhood, his mental illness disrupted his education (he was studying a masters in computer sciences at the time), and his life. He now lives in a rundown apartment in St. Louis, surrounded by other marginal characters (a war veteran suffering from PTSD who never leaves the house, a drug-addict girl whose dealer has become something more personal, an understanding Bosnian landlord…). His main support is his sister Wendy. When she dies, he decides to investigate her death, and things get even more complicated, as his brain starts making connections and seeing coincidences that might or might not be really there.

Brendan is the perfect example of an unreliable narrator. His mental illness makes him misinterpret things, give ominous meanings to random events, and believe that everything that happens relates to him and “the code”. Brendan hears voices, abusive voices, mostly in the second person, that give him orders, insult him, tell him to harm himself and others… He has a complex system of paranoid delusions, all related to a “code” he believes was implanted in his brain, and he is convinced that there is a conspiracy of various agencies (mostly men dressed in dark suits driving black SUVs) that will stop at nothing to try and recover that information. Thanks to his parents’ money (as this is the USA, his access to care would be limited otherwise) he sees a psychiatrist once a week, but he rarely takes medication, as he is convinced that if he does, he won’t be able to escape these agents that are after him. Yes, the medication helps with the voices, but it does not seem to touch his delusions (if it is all a delusion). There are several points in the novel when Brendan ends up in hospital and is given medication, and then he seems to hold it together for a while, enough to go after some clues and make some enquiries, but the longer he goes without medication, the more we doubt anything we read and wonder if any of the connections his brain makes are real or just a part of his illness.

I thought the depiction of Brendan’s mental illness and symptoms was very well done. It brought to my mind conversations with many of my patients, including his use of loud music or the radio to drown the voices, his feelings about the medication, his self-doubt, the attitude of others towards him (most of the characters are very understanding and friendly towards Brendan, although he faces doubt and disbelief a few times, not surprisingly, especially in his dealings with the police and the authorities), and his thought processes. He is a likeable and relatable character, faced with an incredibly difficult situation, but determined to keep going no matter what. His sister’s death motivates him to focus and concentrate on something other than himself and his own worries, and that, ultimately, is what helps him move on and accept the possibility of a more positive future. He also shows at times, flashes of the humour that was in evidence in the author’s previous novel, although here less dark and less often (as it again fluctuates according to the character’s experiences).

The narration is fluid and fast, the pace changing in keeping with the point of view and the mental state of the protagonist. There are clues to the later discoveries from early on (and I did guess a few of the plot points) although the narrator’s mental state creates a good deal of confusion and doubt. The rest of the characters are less well-drawn than Brendan, although that also fits in with the narration style (we only learn as much as he tell us or thinks about them at the time, including his doubts and suspicions when he is not well), and the same goes for his altered perceptions of places and events (sometimes offering plenty of detail about unimportant things, and others paying hardly any attention at all).

Where the book did not work that well for me was when it came to the mystery/thriller part of it. There are inconsistencies and plot holes that I don’t think can be put down to the mental state or the altered perception of the character. There is an important plot point that did not fit in for me and tested my suspension of disbelief (in fact made me wonder if the level of unreliability extended beyond what the novel seemed to suggest up to that point and I became even more suspicious of everything), and I suspect readers who love police procedural stories will also wonder about a few of the things that happen and how they all fit together, but, otherwise, there are plenty of twists, and as I said, the build-up of the character and the depiction of his world and perspective is well achieved. Although the subject matter includes drugs, overdoses, corruption, child neglect, difficult family situations, abuse, adultery, and murder, there is no excessive or graphic use of violence or gore, and everything is filtered through Brendan’s point of view, and he is (despite whatever the voices might say) kind and warm-hearted.

I recommend it to readers interested in unreliable narrators, who love mysteries (but perhaps not sticklers for details or looking for realistic and detailed investigations), and are keen on sympathetic psychological portrayals of the everyday life of a young man suffering from schizophrenia.